Status:
COMPLETED
ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter observational study in patients with rheumatoid arthritis in routine clinical practice in Italy. In the retrospective Part 1 of the study, clinical and demographic factors associ...
Eligibility Criteria
Inclusion
- Part 1:
- Adult patients, \>/= 18 years of age
- Diagnosis of rheumatoid arthritis according to American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) criteria
- Patients who received at least one cycle of biologic therapy, either in monotherapy or in combination, in the 12 months preceding the opening of the first site
- Part 2:
- Patients on monotherapy with RoActemra/Actemra already enrolled in Part 1 of the study
Exclusion
- Patients simultaneously participating in other studies with RoActemra/Actemra at the time of signing informed consent
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT01791205
Start Date
May 1 2013
End Date
October 1 2014
Last Update
January 10 2017
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Bari, Apulia, Italy, 70124
2
Martina Franca, Apulia, Italy, 74015
3
Reggio Calabria, Calabria, Italy, 89133
4
Napoli, Campania, Italy, 80131